| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |